September 17, 2015 article Pharmacokinetic Properties of a Novel d-Peptide Developed to be Therapeutically Active Against Toxic β-Amyloid Oligomers Pharmaceutical Research DOI: 10.1007/s11095-015-1791-2 OpenAlex Authors 0 Author list not loaded yet. Cited by 3 stored of 47 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival 2023 Biomedicines article Medicine Amyotrophic Lateral Sclerosis Research Open access 5 citations Evaluation of the 18F-labeled analog of the therapeutic all-D-enantiomeric peptide RD2 for amyloid β imaging 2023 European Journal of Pharmaceutical Sciences article Medicine Alzheimer's disease research and treatments Open access 5 citations A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model 2021 Molecules article Medicine Amyotrophic Lateral Sclerosis Research Open access cited by 1 patent 12 citations 3 results References 0